Protein–Protein Interactions: Putting the pieces together  by Bax, Ben & Jhoti, Harren
PROTEIN-PROTEIN INTERACTIONS
Putting the pieces together
What do the recently determined crystal structures of 14-3-3 proteins and
of a complex between part of the protein kinase Raf and the Ras-related
protein Rap tell us about how 14-3-3 and Ras regulate the function of Raf?
Ras acts as a molecular switch by cycling between an
active, GTP-bound conformation, which recognizes
effector molecules, and an inactive, GDP-bound confor-
mation. Ras can be turned on by an intracellular sig-
nalling pathway initiated when ligand binds to a
transmembrane growth-factor receptor. Ligand binding
induces autophosphorylation of tyrosine residues in the
cytoplasmic region of the receptor; the phosphorylated
tyrosines are targets for binding by the linker molecule
Grb2, which in turn leads to translocation of a Grb2-Sos
complex from cytosol to plasma membrane. Sos, named
for the Drosophila gene Son-of-sevenless, is a GTP-GDP
exchange factor for Ras, and its translocation to the
plasma membrane allows it to stimulate the exchange of
GTP for GDP on Ras, switching Ras to an active, GTP-
bound conformation.
The determination of crystal structures of Ras in both
the GDP-bound form and complexed with non-
hydrolyzable GTP analogues revealed that the y-phos-
phate of GTP induces conformational changes in two
regions of the protein: switch I (residues 30-38) and
switch II (residues 60-76) [1]. The switch I region of Ras
overlaps with the effector region (residues 32-40), which
contains amino-acid residues known to be involved in
interactions with downstream effector molecules such as
the serine/threonine protein kinase Raf and phos-
phatidylinositol 3-kinase (PI 3-kinase). The mechanism
by which Ras activates Raf involves sequestering the
cytosolic kinase to the plasma membrane by a direct asso-
ciation between the two proteins that is mediated by
Raf's amino-terminal Ras-binding domain (RBD) [2].
The crystal structure of the Raf RBD bound to the Ras
homologue RaplA hereafter Rap) [3] has recently been
determined at 2.2 A resolution, and provides a firm
structural basis for understanding the interaction between
Ras and Raf. The Rap family of GTP-binding proteins
[4] are closely related to the Ras family (overall sequence
identity 50 %) and have an identical effector region
(residues 32-40; YDPTIEDSY in the single-letter
amino-acid code). Indeed, the part of the complex con-
sisting of Rap and the non-hydrolyzable GTP analogue
GppNHp has a very similar structure to Ras complexes
with GTP analogues. A few residues close to the inter-
face - notably Tyr 32, Thr 35 and Ile 36 - do have dif-
ferent conformations in the Rap-RBD complex than in
a Ras-GppNHp complex, but whether this difference is
a result of binding to the Raf RBD is not, at present,
clear. Minor differences in the structure more distal from
Fig. 1. (a) A ribbon representation of the complex between Rap and the Raf RBD 13]. The RBD is shown in red and Rap in yellow. The
interaction is centred round an anti-parallel sheet between strands B2 of the RBD and 32 of Rap. (b) The network of hydrogen bonds
at the Rap-RBD interface, centred around RBD residue Arg 89 (at the carboxyl terminus of the Al helix) and Rap residue Asp 38 (from
the 32 strand). (Reproduced with permission from [3].)
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Fig. 2. Two approximately perpendicular views of 14-3-3 [14]. A 16 residue sequence - the carboxy-terminal end of (x helix 5 and
the loop between helices 5 and 6 - that has been implicated in binding to protein kinase C is highlighted in red (see [141 for more
details). Liu et al. [15] suggest that hydrophobic residues from helices 7 and 9 (shown in green) and hydrophilic residues from helices 3
and 5 (shown in blue) may bind an amphipathic helix on the target protein (not shown). Also shown in red is residue 185, an important
in vivo phosphorylation site in 14-3-3 and .
the Rap-RBD interface are presumably due to sequence
differences between Rap and Ras. For example, Thr 61
of Rap, equivalent to Gln 61 in Ras, coordinates a water
molecule which is close (3.6 A) to the y-phosphate. The
structure of the Raf RBD (residues 51-131) in the com-
plex is similar to that observed in solution [5,6], with a
topology that has previously been observed for ubiquitin.
The interface between Rap and the RBD is centred
around an anti-parallel 3-sheet interaction between
strands 132 of Rap (residues 37-46) and B2 of the RBD
(Fig. 1). The crystal structures of two other small GTP-
binding proteins, ADP-ribosylation factor (ARF) and
Ran [7-9], have recently been determined in the GDP-
bound conformation, and both show the presence of an
extra strand compared to Ras, 132E, which is anti-
parallel to the 2 strand and occupies a similar position
to the B2 strand of the RBD domain in the Rap-RBD
complex.
The Rap-RBD interface is dominated by hydrogen
bonds and polar interactions from charged residues. In
addition to the two hydrogen bonds between the back-
bone atoms of the strands, which result in a continuous
anti-parallel 13 sheet between the two molecules, there is
also an intricate hydrogen-bond network involving
sidechains of RBD and Rap residues. The importance of
electrostatic interactions between Arg 89 of RBD and
Asp 38 of Rap (Fig. 1) is reflected by the dramatic reduc-
tions in the affinity of Ras for Raf that result from muta-
tions of either of these residues (see [3] for references).
These studies suggest that, although the surface area
buried on complex formation is -1200 A2, a significant
amount of the binding energy may be due to a few key
residues. These details have important implications, as the
Ras pathway has attracted much attention as a target for
anti-cancer agents. Now that the RBD-Rap structure is
known, the spatial locations of these key interface
residues may assist in identifying small molecules that are
capable of disrupting this interaction and thus provide
leads for the development of anti-cancer drugs.
Interest in the highly conserved 14-3-3 family of proteins
[10] has recently intensified with the discovery that these
proteins can also bind to and regulate Raf (reviewed in
[11,12]). For example, expression of the 14-3-3 5 isoform
in Xenopus oocytes enhances Raf activity and promotes
oocyte maturation [13]. The recently reported crystal
structures of the T [14] and [15] isoforms of 14-3-3
show that each subunit in the 14-3-3 dimer consists of
nine ot helices, arranged to form almost a right-angle cor-
ner (Fig. 2). The two subunits come together to give an
unusually shaped dimer which resembles a channel or
clamp; the amino-terminal helices of the two subunits
contact one another and form the floor of the channel,
while the carboxy-terminal helices form the walls. The
inner surface of the channel is highly conserved amongst
different isoforms of 14-3-3, suggesting that it may be a
binding site for a conserved protein module or motif.
As yet, no well-conserved motif has been identified
among the different proteins that have been found to be
associated with and/or activated by 14-3-3 proteins,
which include protein kinase C (PKC), middle-T anti-
gen, phospholipase A2 and tyrosine hydroxylase (see
[11,12] for more details). Raf and PKC, however, do
have homologous cysteine-rich zinc-binding domains
[16], which seem to be involved in the interaction with
14-3-3 proteins. Jones et al. [17] have shown that 14-3-3
proteins can form heterodimers and suggested that such
heterodimers might function to bring two different
signalling molecules together. The idea that a 13/g 14-3-3
heterodimer, say, brings together PKC and Raf, allowing
PKC to phosphorylate and activate Raf is attractive but
unproven, and the in vivo functions of 14-3-3 proteins are
not yet clear.
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The hypothesis that 14-3-3 heterodimers may act to link
Raf and activating kinases, such as PKC, suggests a possi-
ble mechanistic connection between the way Ras and
14-3-3 proteins activate Raf. The role of Ras seems to be
to translocate Raf to the plasma membrane, where it can
be activated by phosphorylation on residues Tyr 340 and
Tyr 341 by kinases such as Src or Lck [18]. But the
notion that Raf can be turned on by either Ras and
Src/Lck or by a 14-3-3 heterodimer and PKC is likely to
be an oversimplification. Other mechanisms of regulating
Raf activity may involve phosphatases [19], and recent
reports suggest [gy subunits of trimeric G proteins can
also interact directly with Raf [20]. Furthermore, Raf
may have other substrates than the one known so far, the
MAP kinase kinase known as MEK [21].
The structures of several pieces in the Raf signalling
pathway puzzle have been determined, but others remain
to be solved. The crystal structures of 14-3-3 and the
Rap-RBD complex are clearly landmarks in explaining
Ras function, and may allow novel approaches for anti-
cancer drug design. More pictures of signalling compo-
nents in complex are required before we can put all the
pieces together.
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